Implementing a Liver Contrast Program in the Sonography Laboratory – A White Paper
Mar 4, 2020 — Journal of Diagnostic Medical Sonography The Society of Diagnostic Medical Sonography (SDMS) is pleased to announce the publication of a white paper on implementing a liver contrast program in the sonography laboratory in the January/February 2020 issue of the In 2016 the Food and Drug Administration (FDA) approved contrast-enhanced ultrasound (CEUS) […]
Contrast enhanced ultrasound: comparing a novel modality to MRI to assess for bowel disease in pediatric Crohn’s patients
April 5, 2020 — Translational Gastroenterology and Hepatology Abstract Background: To demonstrate the feasibility and reliability of a novel imaging modality, contrast enhanced ultrasound (CEUS), in evaluating for distal small bowel inflammation in pediatric Crohn’s disease (CD), and compare this to concurrently obtained magnetic resonance imaging (MRI) findings. Methods: Pediatric patients diagnosed with or having […]
Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series
February 26, 2020 — American Journal of Roentgenology Abstract: OBJECTIVE. The contrast-enhanced ultrasound (CEUS) imaging features of hepatic vascular tumors in infants, including infantile hemangioma (IH) and congenital hemangioma (CH), are not well reported. Frequent inaccurate use of lesion terminology in the literature has created diagnostic confusion. The purpose of this study is to describe […]
Contrast-enhanced ultrasound with dispersion analysis for the localization of prostate cancer: correlation with radical prostatectomy specimens
February 20, 2020 — World Journal of Urology Authors: Arnoud W. Postema, Maudy C. W. Gayet, Ruud J. G. van Sloun, Rogier R. Wildeboer, Christophe K. Mannaerts, C. Dilara Savci-Heijink, Stefan G. Schalk, Amir Kajtazovic, Henk van der Poel, Peter F. A. Mulders, Harrie P. Beerlage, Massimo Mischi & Hessel Wijkstra Abstract Purpose To determine […]
Hysterosalpingo-contrast-sonography vs. magnetic resonance-hysterosalpingography for diagnosing fallopian tubal patency: A systematic review and meta-analysis
February 12, 2020 — European Journal of Radiology Abstract Purpose To compare hysterosalpingo-contrast-sonography (HyCoSy) and magnetic resonance-hysterosalpingography (MR-HSG) in the diagnosis of fallopian tubal patency. Materials and methods The databases of PubMed, Embase, and the Cochrane Library were searched for records up to November 30, 2019. Studies involved in the diagnostic detection of HyCoSy or […]
Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?
February 8, 2020 — Clinical Imaging Authors: Zehao Tan, Wey Chyi Teoh, Kang Min Wong, Gervais Khin-Lin Wansaicheong, Kumaresan Sandrasegaran 2020DOI:https://doi.org/10.1016/j.clinimag.2020.02.002 Abstract Purpose To study the comparative performance of contrast-enhanced ultrasound (CEUS) and contrast-enhanced CT or MRI (CECT/MR) in evaluating liver lesions using the LI-RADS guidelines. Methods Retrospective analysis of radiology database from July 2010 […]
The 34th Annual Advances in Contrast Ultrasound International Bubble Conference 2019
Echo Research and Practice Authors: Stella Kyung, Alan Brett Goldberg, Steven Feinstein, Stephanie Wilson, Sharon L. Mulvagh and Petros Nihoyannopulos Read full article at: https://erp.bioscientifica.com/view/journals/echo/aop/erp-19-0055/erp-19-0055.xml Abstract The 34th annual Advances in Contrast Ultrasound (ACU) International Bubble Conference convened in Chicago, IL on September 5-6, 2019 to feature new directions of research, pre-clinical and first-in-man clinical […]
Lantheus touts new study on contrast echocardiography
February 4, 2020 — AuntMinnie.com By AuntMinnie.com staff writers Lantheus Medical Imaging parent company Lantheus Holdings announced the results of its Benefit 1 clinical trial, which evaluated the potential advantages of using its Definity ultrasound contrast agent to evaluate heart failure. The trial results indicated that contrast-enhanced echocardiography led to statistically significant improvements in measurements […]
New Aspects of Ultrasound-Mediated Targeted Delivery and Therapy for Cancer
January 21, 2020 — Dovepress Authors: Yuhang Tian,* Zhao Liu,* Haoyan Tan, Jiahui Hou, Xin Wen, Fan Yang, Wen Cheng Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin 150080, People’s Republic of China DOI https://doi.org/10.2147/IJN.S201208 Abstract: Ultrasound-mediated targeted delivery (UMTD), a novel delivery modality of therapeutic materials based on ultrasound, shows great potential in […]
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes:
The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) European Heart Journal — January 14, 2020 Authors: Juhani Knuuti, William Wijns, Antti Saraste, Davide Capodanno, Emanuele Barbato, Christian Funck-Brentano, Eva Prescott, Robert F Storey, Christi Deaton, Thomas Cuisset et al European Heart Journal, Volume 41, […]
Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound
January 8, 2020 — European Radiology Authors: Dan Liu, Fei Liu, Xiaoyan Xie, Liya Su, Ming Liu, Xiaohua Xie, Ming Kuang Guangliang Huang, Yuqi Wang, Hui Zhou, Kun Wang, Manxia Lin, Jie Tian https://doi.org/10.1007/s00330-019-06553-6 Abstract Objectives We aimed to establish and validate an artificial intelligence–based radiomics strategy for predicting personalized responses of hepatocellular carcinoma (HCC) […]
Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection
January 8, 2020 — Uro Today Authors: I Gupta, B Freid, V Masarapu, P Machado, E Trabulsi, K Wallace, E Halpern, F Forsberg Thomas Jefferson University, Philadelphia, PA 19107, USA., GE Global Research, Niskayuna NY 12309, USA., Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: flemming.forsberg@jefferson.edu. http://www.ncbi.nlm.nih.gov/pubmed/31899231 To assess the PCa detection rates of […]
World’s first cancer treatment being trialed in NHS hospitals could make chemotherapy 'more effective by using BUBBLES to help kill tumors'
Acoustic cluster therapy involves injecting microbubbles and liquid droplets Ultrasound used to make bubbles grow larger and stretch the tumor’s walls Increases chance of chemo drugs reaching cancer cells and not healthy ones Daily Mail (Online) — December 18, 2019 By Connor Boyd, Health Reporter NHS hospitals are trialling a world-first way of delivering chemotherapy […]
Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma
Uro Today — December 6, 2019 Vena cava thrombus is one of the main clinical manifestations of locally aggressive renal cell carcinoma (RCC). Inferior vena cava (IVC) wall invasion and presence of bland thrombus could affect the surgical outcome. This study aims to assess the value of contrast-enhanced ultrasound (CEUS) in detecting wall invasion and […]
Ultrasound Can Open Blood-Brain Barrier; Treatment could improve drug penetration and toxin removal in Alzheimer's patients
December 05, 2019 — MedPage Today By Ed Susman In preliminary studies, focused ultrasound directed at the blood-brain barrier briefly made it more porous, which could be a means to allow drugs into Alzheimer’s patients’ brains or permit toxins to escape. In the phase II safety trial, researchers treated three women diagnosed with Alzheimer’s disease […]
The Safety and Effectiveness of Intravenous Contrast-Enhanced Sonography in Chinese Children—A Single Center and Prospective Study in China
December 5, 2019 — Frontiers in Pharmacology Background and Objective: Intravenous contrast-enhanced ultrasound (CEUS), using the second-generation ultrasound contrast agent SonoVue®, has been widely used in adults. In 2016, it was approved for pediatric applications by the American Food and Drug Administration (FDA). However, it has not been approved by the Chinese Food and Drug […]
Pediatric CEUS Usage Growing Very Fast
Dec 2, 2019 — ICUS By Kassa Darge, MD Diagnostic imaging can be a great tool in saving life. However, x-ray, CT and MRI come at a price for children. Radiation, need for sedation or anesthesia and potential serious adverse events of some of the contrast agents are major hurdles to carrying out these studies. […]
FDA Approves Ultrasound Enhancing Agent for Use in Pediatric Patients
Dec 2, 2019 — Pharmacy Times By Aislinn Antrim, Assistant Editor Officials with the FDA have approved sulfur hexafluoride lipid-type A microspheres for injectable suspension (Lumason, Bracco Diagnostics Inc), for use in echocardiography in pediatric patients. This is the drug’s fourth indication approved by the FDA. The contrast agent is newly indicated to opacify the […]
Can CEUS with second generation contrast agents replace CT angiography for distinguishing between occlusion and pseudo-occlusion of the internal carotid artery?
Clinics (Sao Paulo) January, 2015 Carlos Augusto Pinto Ventura,I Erasmo Simão da Silva,II Giovanni Guido Cerri,I Pedro Puech Leão,IV Adriano Tachibana,I Maria Cristina ChammasIII I Hospital das Clı´nicas da Faculdade de Medicina da Universidade de São Paulo, Department of Radiology, São Paulo/SP, Brazil. II Faculdade de Medicina da Universidade de São Paulo, Department of Surgery, […]
Sound waves and microbubbles to tackle tumours
The Times — November 13, 2019 By Rhys Blakely, Science Correspondent Scientists have developed a means of using sound waves to track and manoeuvre tiny parcels of drugs to precise locations inside the body. The technique could be used to ferry powerfully toxic cancer treatments to tumour sites, avoiding damage to surrounding tissues and dramatically […]
